Drugs / Gem
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03251313 Background | May 2019 → Dec 2022 | triple-negative breast carcinoma | Fudan University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gem | “Gem 1000mg/m2 d2,9” NCT03251313 ↗ |